Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, et al: Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons
For research protocols requiring precise pharmacokinetic tracking of retatrutide plasma levels, the injection site should be standardized and documented consistently across study subjects and time points
10.1016/0026-0495(66)90156-9 Metabolism 108 VillanuevaM
June 12, 2025
Semaglutide and liraglutide, two leading GLP-1 drugs, demonstrated significant weight reduction in clinical trials, with semaglutide achieving up to 15% body weight loss over 68 weeks